State coverage
Medicaid, for obesity: Covers with conditions. Coverage survived January 1, 2026, but only for morbid obesity after every other treatment has failed.
Michigan is the state that shows why counting states is the wrong way to read this. It did not end coverage, so every tally still lists it as covering. What it did on January 1, 2026 was rewrite the conditions hard enough that the listing and the reality have drifted apart.
The trigger was budget legislation, Public Act 22 of 2025, and the state's letter to providers says plainly that coverage "will be reduced." Three requirements arrived with it: you must be classified as morbidly obese, every other clinically appropriate weight-loss treatment must have been tried and documented as failed, and your prescriber has to attest that the drug is being used to avert the need for bariatric surgery. That last one is not a clinical threshold at all. It reframes the drug as the cheaper alternative to an operation.
So Michigan covers, and this page says so. Whether you can get through the gate is a different question from whether the state pays, and the criteria below are the ones your prescriber will be answering.
Michigan reduced this coverage on January 1, 2026 under Public Act 22 of 2025, the budget legislation. The state's letter to providers says coverage of GLP-1 medications "when prescribed solely to treat obesity, including requests for continuation, will be reduced," while coverage for other indications "will not be changing." It sets three new requirements: the patient "must be classified as morbidly obese"; coverage is "contingent on documented failure of all other clinically appropriate weight-loss interventions"; and it is available "only as a measure to avert the need for higher-cost bariatric surgery."
Michigan Department of Health and Human Services, effective January 2026 · source · read August 2026
The criteria document puts numbers on it. For adults, the prescriber attests to "an initial body mass index (BMI) classified as morbidly obese (e.g., baseline BMI ≥ 40 kg/m2 or greater)." Before that, there must be trial and failure with all five types of preferred non-GLP-1 agents — the document names benzphetamine, diethylpropion, orlistat products, phendimetrazine and phentermine — or a contraindication or unacceptable side effects across all five.
Michigan Department of Health and Human Services, effective September 2026 · source · read August 2026
Approval runs six months at a time, initial and renewal alike, and keeping it requires results: the prescriber must document "that the patient has maintained a weight loss of ≥ 5% from baseline weight at initiation of therapy." There is also a separate, tighter gate for people who started before the rules changed — at first renewal they must be shown to have met the new morbid-obesity, failed-interventions and avert-surgery tests as of when they began.
Michigan Department of Health and Human Services, effective September 2026 · source · read August 2026
Your health plan cannot be stricter than this. Michigan requires its Medicaid Health Plans to follow the same drug list the fee-for-service program uses: "Effective for dates of service on or after October 1, 2020, [MDHHS] Policy Bulletin 20-51 will require Medicaid Health Plans (MHPs) to follow the Michigan PDL used by the Fee-for-Service (FFS) pharmacy program. This will be described as the Single PDL."
Michigan Department of Health and Human Services, effective August 2026 · source · read August 2026
If you are refused, Michigan's manual says a denial of prior authorization is one of the decisions you can appeal, and that "the client or AHR has 90 calendar days from the date of the written notice of case action to request a hearing," with the request needing to reach the local office inside those 90 days. If you are in a managed care plan you must finish that plan's internal appeal first before you can ask the state for a hearing.
Michigan Department of Health and Human Services, Bridges Administrative Manual 600, effective May 2026 · source · read August 2026
Medicaid is only one of the routes. If you have a commercial or employer plan, the rules are different and are on the employer plans page; Medicare has a federal rule of its own, on the Part D page.
If the appeal fails, or you cannot wait
Cash-pay telehealth is the fallback, not the bargain: you pay the whole cost yourself, and a covered prescription is almost always cheaper than any of these. Use this route when coverage has actually been exhausted, or when you need to start while an appeal runs.
These companies pay us a commission if you start care through the links below. That is how this site is funded, and it does not change what is written above. How we pay for this.
Prices in those notes were read from each company's own site in August 2026 and change often. Check the current number before you buy.
Every state we have verified is in the coverage matrix. Appeal routes and deadlines are on the procedures page.